DL Chemical and Hanwha Solutions Struggle with Prolonged Losses Amid Weak Petrochemical Market

Reporter Paul Lee / approved : 2025-08-14 03:34:28
  • -
  • +
  • 인쇄

DL Chemical plant at Yeosu Industrial Complex (Photo courtesy of DL Chemical)
 

 

 

[Alpha Biz= Paul Lee] DL Chemical posted second-quarter standalone sales of ₩367.2 billion, down 28.7% from the same period last year, according to the company’s July earnings release. Operating profit plunged 67.1% year-on-year to ₩24.4 billion. While the company’s proprietary polybutene (PB) business continues to deliver strong profitability, earnings from polyethylene (PE) have fallen due to intensified competition and sluggish market conditions.



DL Chemical has been in the red since 2022, recording net losses of ₩102.4 billion in 2022, ₩329.4 billion in 2023, and ₩304.7 billion so far in 2024. As of March this year, accumulated deficits totaled ₩724.4 billion, and the company is also under pressure to provide financial support to its affiliate, Yeochun NCC.



Hanwha Solutions faces a similar challenge. The company reported consolidated operating profit of ₩102.1 billion in the second quarter, turning a profit from a loss a year earlier, with sales up 17.55% to ₩3.1173 trillion. However, excluding ₩182.0 billion in U.S. Inflation Reduction Act (IRA) subsidies included in operating profit, the quarter would have ended in a loss.



By segment, Hanwha Solutions’ chemical division has now posted operating losses for seven consecutive quarters since Q4 2023. Global oversupply has pushed selling prices down, and the company expects the division to remain in the red in the third quarter, extending losses over a two-year period.

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

어플

주요기사

Shinhan Investment Raises LG Innotek Target Price to ₩280,000 on Earnings Recovery and 2025 Growth Outlook2025.10.31
Woori Bank Sanctioned by Financial Supervisory Service for Delayed Reporting of Overseas Regulatory Actions2025.10.31
Samyang Foods Raises U.S. Supply Prices for Buldak Ramen Amid Tariff Impact2025.10.31
NH Investment & Securities Suspends IB Executive Under Investigation for Alleged Insider Trading2025.10.31
Heungkuk Life to Secure KRW 840 Billion in Liquidity Through Headquarters Sale and Bond Issuance — Preparing for AIGIS Asset Management Acquisition Bid2025.10.31
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사